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Abstract
One-third of people living with dementia also experience depression. Treating symptoms of depression may 
be a protective factor and reduce cognitive decline in dementia. People suffering from depression experience 
sad mood, reduced energy, poor concentration, loss of interest, diminished activity and they are at risk for 
death by suicide. Screening instruments include the Cornell Scale for Depression in Dementia (CSDD) and the 
Geriatric Depression Scale (GDS). Typical treatments include antidepressant medications, which may have 
limited efficacy; and Electroconvulsive Therapy (ECT), which may heighten memory loss. Psychotherapeutic 
approaches, including cognitive–behavioral therapy, interpersonal therapy and supportive counseling can be 
helpful. Lifestyle modifications addressing healthy diet, exercise and the inclusion of enjoyable activities can 
promote improved quality of life.  Providing needed education and support to caregivers, who often experience 
depression, anxiety and sleep disorders themselves is critical. This paper provides health professionals with 
an overview of approaches for recognizing and responding to co-occurring dementia and depression.
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Introduction
Co-occurring dementia and depression, particularly in older adults, presents unique challenges 
for health care practitioners. Symptoms of dementia, such as deterioration in memory, thinking, 
behavior and the ability to perform everyday activities [1] can appear similar to symptoms of 
depression, which include sad mood, reduced energy, poor concentration, loss of interest and 
diminished activity [2]. Approximately 32% of people living with dementia are also likely to 
experience depression [3].
In the 2017 Draft Global Action Plan on the Public Health Response to Dementia, the World 
Health Organization (WHO) identified that preventing and managing depression may be a 
protective factor and reduce the risk of cognitive decline in dementia [4]. Existing research has 
focused on diagnosing depression in dementia and evaluating treatment with antidepressant 
medications. Most of this work has been directed to physicians. However, health professionals from 
a variety of different settings encounter people struggling to cope with co-occurring dementia and 
depression in their practice. Increasing understanding of depression among all members of health 
care teams can make an important difference in helping to prevent decline in dementia. Geared to 
a multidisciplinary audience, this article explains approaches for recognizing and responding to 
depression in dementia.
Defining Dementia
Dementia, or neurocognitive disorder is a syndrome characterized by an acquired and observable 
decline in cognition in one or more cognitive domains such as learning and memory, language, 
executive function, complex attention, perceptual-motor, and social cognition [5]. As many as 36 
million people currently live with dementia and this number is expected to double every 20 years 
[6]. 10% of people 65 years of age and older have dementia [7].
Many conditions are considered potential causes of dementia. These include Alzheimer’s Disease 
(AD), Vascular Dementia (VaD) and Lewy body dementia. Alzheimer’s disease is the most common 
form of dementia and accounts for almost 80% of cases of dementia [8]. Vascular dementia, a form 
of brain damage caused by impaired blood flow to the brain because of diseased blood vessels [9] 
is the second most common form of dementia and affects about 20% of the dementia population 
[10]. Although the true frequency of Lewy body dementia is unclear, this condition is increasingly 
becoming recognized as a common cause of dementia in older people [11]. In this article, the term 
dementia will refer to dementia caused by Alzheimer’s disease. Unless otherwise specified, the 
information presented can be considered relevant to the care of people experiencing any form of 
dementia.
Recognizing Depression 
The decline in neurocognitive function and memory impairment that people with dementia 
experience reduces both their own quality of life and that of their caregivers [12]. Neuropsychiatric 
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symptoms, such as depression, also compromise quality of life and 
have even been related to faster progression of dementia symptoms 
[13]. 97% of people with dementia experience neuropsychiatric 
symptoms, and 29-47% of these are depression [14].
Types of Depression
Differentiating among varied types of depression, or feelings of 
overwhelming sadness, is foundational to the process of recognizing 
depression in dementia. Major (clinical) depression; persistent 
depressive disorder (dysthymia); adjustment disorder with depressed 
mood; Seasonal Affective Disorder (SAD); and late life depression are 
five common types of depression. Major depression is characterized 
by either a depressed mood or a loss of interest or pleasure in daily 
activities that occurs consistently for at least a 2 week period [5]. This 
acute depressed mood signals a significant change from the person’s 
normal mood; is in addition to a normal response to significant 
loss; and it negatively impacts social, occupational, educational and 
everyday functioning [5]. 
Persistent depressive disorder also involves depressed mood and 
loss of interest, but the symptoms are chronic, occur for more than 2 
years and may not fully impair functioning [5]. People with persistent 
depressive disorder often also experience co-occurring bouts of major 
depression [15]. 
Adjustment disorder with depressed mood can occur at times 
when people are facing a change or new and stressful life event [5]. 
The life event can be positive, such as experiencing a marriage or a 
new baby in the family; or it can be negative such as experiencing an 
illness or moving to a care facility.
Seasonal affective disorder is related to variations in light 
exposure in different seasons and occurs most frequently in winter 
[5]. Symptoms include overeating, craving carbohydrates and 
sleeping too much or too little [16]. While these symptoms also occur 
in other types of depression, SAD is diagnosed when people have a 
consistent pattern of experiencing the same seasonal depression for 
several years.
Late-life depression frequently occurs when people experience age 
related physical illnesses such as arteriosclerosis [5]. Arteriosclerosis 
in the elderly may induce vascular neurocognitive disorder (vascular 
dementia) [5], which in many cases may explain the co-occurrence 
of late-life depression. Symptoms primarily impair executive 
functions, attention, information processing, psychomotor speed 
and working memory [5]. Chronic inflammation, hormonal, and 
immune issues can impact the integrity of frontostriatal circuits as 
well as the amygdala and the hippocampus, ultimately increasing the 
vulnerability to depression [17]. Older adults living with psychosocial 
stressors such as poor socioeconomic status, disability, and social 
isolation are particularly vulnerable to late-life depression [18]. In 
old age, depressive symptoms have an association with cognitive 
decline [19]. Associations between late-life depression and dementia, 
although not conclusive, are increasingly being questioned and 
investigated [20-23].
It is important to emphasize that suicidal ideation (thoughts 
of suicide) can be expected in any type of depression. The risk of 
suicide is significant in the elderly. For example, rates of death by 
suicide in men over age 70 are higher than in any other demographic 
group worldwide [24]. People with dementia who are most at risk of 
suicide are male, receiving or have a history of receiving treatment 
for psychiatric symptoms and newly diagnosed with dementia [25]. 
Whenever health professionals determine that individuals in their 
care are experiencing depression, it is critical to question and report 
whether suicidal ideation is present. 
Treatment approaches for the types of depression mentioned 
above differ. While time-limited support may be fitting for major 
depression, adjustment disorder and seasonal affective disorder, 
more long term approaches will likely be needed for persistent and 
late-life depressions. In this article, the term depression will refer to 
major, persistent and late-life depressions. Unless otherwise specified, 
the information presented can be considered relevant to the care of 
people experiencing any type of depression.
Screening for Depression
An important first step in the process of recognizing depression 
in dementia is to remain aware that overwhelming sadness, loss of 
interest in activities once enjoyed and changes in eating and sleeping 
patterns are symptoms of depression and not part of normal aging. 
Another important step is to invite people with dementia to talk about 
their feelings, even when cognitive impairment is present. A further 
step is to document comments from family members which describe 
previous life experiences with depression. This documentation 
should include depressions people have experienced, how they coped 
and treatments that helped. 
Screening tools also play a key role in recognizing depression 
in dementia. Valid rating scales are available to practitioners from 
different disciplines and these can be implemented with people who 
live in the community, in long term care facilities or are temporarily 
being treated in acute settings. Two scales that have been validated for 
use in the older adult population are the Cornell Scale for Depression 
in Dementia CSDD and the Geriatric Depression Scale GDS [26-27]. 
The Cornell Scale for Depression in Dementia, as the name 
implies, was designed specifically for use in dementia, includes 
interview information from both clients and their caregivers and can 
be completed in about 20 minutes [28]. Scores illustrate the severity 
of depression. A score of 0-7 indicates that few depressive symptoms 
are present; one of 8-10 indicates moderate depressive symptoms, 
and >10 indicates major depressive symptoms [28].
The Geriatric Depression Scale (15 item shortened version) is 
a self-report measure and can be used both with older adults who 
have or do not have symptoms of dementia [29]. Using a ‘yes’ or ‘no’ 
format, the scale can be completed in about 5 minutes and the cut-off 
score for depression is 6 points [29]. This scale is considered most 
effective for people with only mild cognitive impairment as internal 
consistency decreases in the later stages of dementia and when used 
with those experiencing moderate to severe dementia [30].
Responding to Depression
Pharmacological Approaches
Antidepressant medications are one important approach in 
the complex treatment of depression in dementia [31] and they 
may be helpful [32]. As many as 88% of people with co-occurring 
dementia and depression are treated with antidepressant medications 
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[33]. Selective Serotonin Reuptake Inhibitors (SSRI’s) (e.g., 
citalopram, escitalopram, paroxetine, sertraline) are the first-line 
pharmacotherapy although mirtazapine, a Selective Norepinephrine 
Reuptake Inhibitor (SNRI) may be useful when insomnia is present 
[34]. Tricyclic antidepressants are usually avoided as they can cause 
anticholinergic effects which may further impair cognitive function 
in people with dementia [34].
Research indicates that evidence of antidepressant efficacy in 
the treatment of depression in people with dementia is inconclusive 
[35-37]. Studies have revealed that people with dementia who are on 
antidepressants have increased odds of further cognitive impairment 
[38]. Independent of depression, the antidepressant medications 
themselves have even been identified as a potential risk factor for 
dementia [39]. Discontinuing antidepressant treatment in people 
with co-occurring depression and dementia can lead to an increase 
in depressive and other neuropsychiatric symptoms [40]. In general, 
antidepressants are recommended mainly for individuals with 
depression where the symptoms are especially distressing and surpass 
the threshold for major depression [41].
Non Pharmacological Approaches
Electroconvulsive Therapy (ECT), which involves the electrical 
stimulation of the brain with the intent of inducing seizures, is a 
viable treatment for depression, especially in urgent situations where 
an immediate treatment response is needed [42]. When symptoms 
of severe agitation are present in people living with dementia, 
electroconvulsive therapy has been found to reduce these symptoms 
[43]. However, the side effects of cognitive impairment and memory 
loss [42] must be taken into consideration when implementing 
electroconvulsive therapy with older adults who are already 
experiencing confusion.
Psychotherapy
Moderate evidence suggests that psychotherapeutic approaches, 
such as Cognitive-Behavioral Therapy (CBT), interpersonal therapy 
and supportive counseling are effective for people living with co-
occurring depression and dementia [44]. Cognitive behavioral 
therapy aims to challenge the distorted and negative ways people 
interpret situations and to support them towards finding new and 
more adaptive views [45]. Interpersonal Therapy (IPT), based on the 
premise that depression is related to interpersonal conflicts, provides 
people with techniques to explore and cope with grief, interpersonal 
conflicts, interpersonal deficits and role transitions [45]. Supportive 
counseling, also referred to a person-centered on non-directive 
therapy, uses principles of warmth, empathy and respect to help 
people explore issues that are important to them [45].
These psychological interventions have the potential to improve 
peoples’ quality of life, cognition, activities of daily living and they may 
reduce caregiver burden [44]. Therapeutic strategies that have been 
used effectively in late-life depression without cognitive impairment, 
such as reminiscing, problem solving and instigating environmental 
changes [45] are not usually implemented in people with dementia.
Lifestyle Modifications
Modifying patterns of diet, exercise and enjoyable activities 
may exert a positive influence on some symptoms of depression. 
Recommendations for modifying dietary patterns include: following 
the Mediterranean diet; increasing consumption of fruits, vegetables, 
legumes, wholegrain cereals, nuts, and seeds; including a high 
consumption of foods rich in omega-3 polyunsaturated fatty acids; 
replacing unhealthy foods with wholesome nutritious foods; and 
limiting intake of processed-foods, ‘fast’ foods, commercial bakery 
goods, and sweets [46].
Exercise, especially activities that stimulate moderate cardio 
respiratory gains, such as 45 minutes of walking, running or 
swimming each day, can improve memory performance and reduce 
hippocampal atrophy in the brain [47-48]. Encouraging both people 
living with co-occurring depression and dementia and their caregivers 
to join exercise classes, walking groups and structured water exercise 
activities can help them maintain healthy exercise regimes.
Enjoyable activities, such as spending individual time with family 
or staff caregivers and ‘walking and talking’ in pleasant surroundings 
may improve mood [49]. Animal-assisted activities, such as petting 
and feeding dogs in sessions facilitated by dog handlers, have also 
been shown to have a positive effect on symptoms of depression 
and quality of life in older adults with dementia, especially those 
in a late stage [50] Music care, for example, playing selected music 
with specific background melodies and rhythms, while inviting 
participants to move in time with the music, can bring much needed 
comfort [51-52]. Massages, usually provided in chairs rather than on 
massage tables, can help people feel less combative and restless [53].
Caregiver Support
Education and ongoing support for caregivers is a critical element 
in the process of responding to depression in dementia. Caregivers can 
be spouses, family members, care facility staff, home support workers, 
volunteers and others who are interested in helping. While caregiver 
burden can be expected to be more severe in family members who are 
closest to those who are suffering, others involved in their care can 
experience distress as well. The burden of caregiving is amplified in 
situations where people are especially frail [54].
Anxiety, depression and sleeping problems are known to occur 
among caregivers of people living with co-occurring depression and 
dementia [55-57]. Caregivers can struggle with feeling incompetent, 
guilty, and overburdened [58]. They can also feel grief and an 
ambiguous sense of loss when people they care for are physically 
with them, but yet not usually mentally or emotionally present in 
the same way as before [59]. Providing needed resources and respite 
for caregivers can in turn help those in their care. Group activities, 
where caregivers can connect with like-minded others and ensuring 
that their time with service providers is not rushed may begin to ease 
the burden.
Conclusion
Dementia, usually caused by Alzheimer’s disease or vascular 
insufficiencies, is characterized by difficulty performing everyday 
activities and deterioration in memory, thinking and behavior. 
Depression, which is also characterized by difficulty performing 
everyday activities, co-occurs in at least one-third of people living 
with dementia. Depression causes overwhelming feelings of sadness, 
loss of interest in activities once enjoyed and changes in eating and 
sleeping patterns.
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Depression can occur acutely as a major or clinical episode, as a 
seasonal affective disorder, or as an adjustment to a new situation. 
It can also occur chronically as a dysthymia or persistent depression 
that extends over several years. Most frequently, it presents as a late 
life depression possibly associated with inflammation, hormonal, and 
immune issues impacting the frontostriatal circuits, the amygdala 
and or the hippocampus. Cognitive decline is associated with late 
life depression, making it especially difficult to differentiate from 
dementia. Neither the symptoms of dementia nor those of depression 
are normal as people age. They are symptoms that significantly 
decrease the quality of life for both those who are afflicted and their 
caregivers.
Remaining vigilant in assessing for these symptoms and 
implementing screening instruments such as the Cornell Scale for 
Depression in Dementia (CSDD) and the Geriatric Depression Scale 
(GDS) are useful elements in the complex process of recognizing 
depression in dementia. Reports from family members or previous 
medical histories documenting any history of depression and 
treatment approaches that helped should be available to all those who 
provide care. When symptoms of any type of depression are observed, 
health professionals from all disciplines are expected to immediately 
assess and report any thoughts of suicide.
Responding to co-occurring depression and dementia is seldom 
straightforward. Typical pharmacological responses, such as selective 
serotonin reuptake inhibitors antidepressant medications, have 
limited efficacy despite their frequent use. Non pharmacological 
responses, such as electroconvulsive therapy, may increase the 
memory impairment already present in dementia. It is prudent to 
reserve the use of antidepressant medications for severely depressed 
people, and the use electroconvulsive therapy for those unable to find 
relief from their agitation through other means.
Psychotherapeutic approaches such as cognitive–behavioral 
therapy, interpersonal therapy and supportive counseling can be 
helpful. Lifestyle modifications addressing healthy diet patterns 
that replace processed items with wholesome nutritious foods; and 
maintaining exercise programs, particularly those that provide 
moderate stimulation to the cardiac and respiratory systems can 
also be helpful. Integrating enjoyable activities which provide 
opportunities for people to spend individual time with family or 
caregivers; to handle animals; to listen to and move with music; and 
to receive a massage all have the potential to improve quality of life.
Caregivers, who play an essential role in the lives of people living 
with depression in dementia, are likely to experience depression 
themselves. They also may be struggling to cope with anxieties, 
sleep disorders and caregiver burden. At times, they can experience 
feelings of incompetence, guilt, grief and an ambiguous sense of loss. 
Providing needed education and support is invaluable. Although 
caregivers are not formally identified as needing services from health 
care professionals, treatment of people with co-occurring dementia 
and depression is incomplete unless the needs of their caregivers are 
also addressed. All those who care for and about people living with 
dementia can contribute to the process of recognizing and responding 
to depression. This is both a challenge and an opportunity for health 
care professionals from all disciplines.
References
1. World Health Organization. Dementia. 2017.
2. World Health Organization. Depression. 2017.
3. Lyketsos CG, Lopez O, Jones B, Fitzpatrick AL, Breitner J, DeKosky S. 
Prevalence of neuropsychiatric symptoms in dementia and mild cognitive 
impairment: Results from the cardiovascular health study. JAMA. 2002; 288: 
1475-1483. 
4. World Health Organization. Draft global action plans on the public health 
response to dementia: report by the Governor General. Seventieth World 
Health Assembly Agenda Item 15.2.
5. American Psychiatric Association. Diagnostic and Statistical Manual of 
Mental Disorders, 5th edn. American Psychiatric Association. 2013.
6. Alzheimer’s disease International. World Alzheimer Report. The global 
impact of dementia. An analysis of prevalence, incidence, cost and trends. 
London, UK, 2015.
7. Alzheimer’s Association. Alzheimer’s disease Facts and Figures. Washington 
DC, 2017.
8. Alzheimer’s disease International. World Alzheimer Report. Dementia and 
Risk Reduction an Analysis of Protective and Modifiable Factors. London, 
UK, 2014. 
9. Venkat P, Chopp M and Chen J. Models and mechanisms of vascular 
dementia. Exp Neurol. 2015; 272: 97-108.
10. Korczyn AD, Vakhapova V and Grinberg LT. Vascular dementia. J Neurol 
Sci. 2012; 322: 2-10. 
11. Vann Jones S and O’Brien J. The prevalence and incidence of dementia with 
Lewy bodies: a systematic review of population and clinical studies. Psychol 
Med. 2014; 44: 673-683. 
12. León-Salas B, Olazarán J, Muñiz R, González-Salvador MT and Martínez-
Martín P. Caregivers’ estimation of patients’ quality of life (QoL) in Alzheimer’s 
Disease (AD): an approach using the ADRQL. Arch Gerontol Geriatr. 2011; 
53: 13-8.
13. Lyketsos CG. Neuropsychiatric symptoms in dementia: an overview and 
measurement challenges. J PrevAlz Dis 2015; 2: 155-156.
14. Steinberg M, Shao H, Zandi P, Lyketsos CG, Welsh-Bohmer KA, Norton MC, 
et al: Point and 5-year period prevalence of neuropsychiatric symptoms in 
dementia: the Cache County Study. Int J Geriatr Psychiatry. 2008; 23: 170–
177.
15. Melrose S. Persistent depressive disorder or dysthymia: An overview of 
assessment and treatment approaches. Open Journal of Depression. 2017; 
6: 1-13.
16. Melrose S. Seasonal affective disorder: an overview of assessment and 
treatment approaches. Depression Research and Treatment. 2016.
17. Sexton CE, Mackay CE and Ebmeier KP. A systematic review and meta-
analysis of magnetic resonance imaging studies in late-life depression. Am J 
Geriatr Psychiatry. 2013; 21: 184-195.
18. Alexopoulos GS. Depression in the elderly. Lancet. 2005; 365: 1961-1970. 
19. Wilson R, Capuano A, Boyle P, Hoganson G, Hizel L, Shah R et al. Clinical-
pathologic study of depressive symptoms and cognitive decline in old age. 
Neurology. 2014; 83: 702-709.
20. Diniz B, Butters M, Albert S, Dew M and Reynolds C. Late-life depression 
and risk of vascular dementia and Alzheimer’s disease: systematic review 
and meta-analysis of community-based cohort studies. The Br J Psychiatry. 
2013; 202, 329-335.
21. Wise J. Depression is not a risk factor for dementia, large cohort study 
concludes. BMJ. 2017; 357: 2409.
22. Steffens DC. Late-life depression and the prodromes of Dementia. JAMA 
Psychiatry. 2017; 74: 673-674.
Page 5/5
Gr   upSM Copyright  Melrose S
Citation: Melrose S. Recognizing and Responding to Depression in Dementia. 
SM J Psychiatry Ment Health. 2017; 2(1): 1008.
23. Wilson R, Boyle P, Capuano A, Shah R, Hoganson G, Nag S. et al. 
Late-life depression is not associated with dementia-related pathology. 
Neuropsychology. 2016; 30: 135-142. 
24. World Health Organization. Preventing suicide: A global imperative. Geneva, 
Switzerland, 2014. 
25. Seyrfied L, Kales H, Ignacio R, Conwell Y and Valenstein M. Predictors of 
suicide in patients with dementia. Alzheimer’s & Dementia: The Journal of the 
Alzheimer’s Association. 2011; 7: 567-573.
26. Kørner A, Lauritzen L, Abelskov K, Gulmann N, Marie Brodersen A, 
Wedervang-Jensen T, et al. The Geriatric Depression Scale and the Cornell 
Scale for Depression in Dementia: a validity study. Nord J Psychiatry. 2006; 
60: 360-364. 
27. Schreiner AS, Hayakawa H, Morimoto T and Kakuma T. Screening for late life 
depression: cut-off scores for the Geriatric Depression Scale and the Cornell 
Scale for Depression in Dementia among Japanese subjects. Int J Geriat 
Psychiatry. 2003; 18: 498-505.
28. Alexopoulos GS, Abrams RC, Young RC and Shamoian CA. Cornell Scale for 
Depression in Dementia. Biol Psychiatry. 1988; 23: 271-284. 
29. Sheikh JI and Yesavage JA. Geriatric Depression Scale (GDS): Recent 
evidence and development of a shorter version. Clinical Gerontologist. 1986; 
5: 165-173. 
30. Müller-Thomsen T, Arlt S, Mann U, Maß R and Ganzer S. Detecting 
depression in Alzheimer’s disease: evaluation of four different scales. Arch 
Clin Neuropsychol. 2005; 20: 271-276.
31. Rabins PV, Rovner BW, Rummans T, Schneider L and Tario P. Guideline 
watch practice guideline for the treatment of patients with Alzheimer’s disease 
and other dementias. Arlington, VA: American Psychiatric Association; 2014.
32. Nelson JC, Devanand DP. A systematic review and meta-analysis of placebo-
controlled antidepressant studies in people with depression and dementia. J 
Am Geriatr Soc. 2011; 59: 577-585. 
33. Bhattacharjee S, Oh Y, Reiman E and Burke W. Prevalence, patterns, 
and predictors of depression treatment among community-dwelling elderly 
individuals with dementia in the United States. Am J Geriatr Psychiatry. 2017; 
25: 803-813. 
34. Kitching D. Depression in dementia. Australian Prescriber. 2015; 38, 209-
211. 
35. Leong C. Antidepressants for depression in patients with dementia: a review 
of the literature. Consult Pharm 2014; 29, 254-263. 
36. Orgeta V, Tabet N, Nilforooshan R and Howard R. Efficacy of antidepressants 
for depression in Alzheimer’s disease: systematic review and meta-analysis. 
J Alzheimer’s Dis. 2017; 58: 725-733.
37. Canadian Agency for Drugs and Technologies in Health. Antidepressants 
in elderly patients with depression and dementia: a review of clinical 
effectiveness and guidelines. Ottawa, ON Canada: 2015. 
38. Moraros J, Nwankwo C, Patten SB and Mousseau DD. The association of 
antidepressant drug usage with cognitive impairment or dementia, including 
Alzheimer disease: A systematic review and meta-analysis. Depress Anxiety. 
2017; 34: 217-226. 
39. Then C, Chi N, Chung K, Kuo L, Liu K, Hu C, et al. Risk analysis of use of 
different classes of antidepressants on subsequent dementia: A nationwide 
cohort study in Taiwan. Plos ONE. 2017; 12: 1-17. 
40. Bergh S, Selbaek G and Engedal K. Discontinuation of antidepressants 
in people with dementia and neuropsychiatric symptoms (DESEP study): 
double blind, randomised, parallel group, placebo controlled trial. 
41. Ford AH and Almeida OP. Management of depression in patients with 
dementia: is pharmacological treatment justified?Drugs & Aging. 2017; 34: 
89-95. 
42. Kolar D. Current status of electroconvulsive therapy for mood disorders: A 
clinical review. Evid Based Ment Health. 2017; 20, 12-14. 
43. Burton M, Koeller S, Brekke F, Afonya A, Sutor and Lapid M. Use of 
electroconvulsive therapy in dementia-related agitation: a case series. J ECT. 
2017. 
44. Orgeta V, Qazi A, Spector A, Orrell M. Psychological treatments for depression 
and anxiety in dementia and mild cognitive impairment: systematic review 
and meta-analysis. BJ Psych. 2015; 207: 293-298. 
45.  Blackburn P, Wilkins-Ho M, Wiese B. Depression in older adults: Diagnosis 
and management. BC Medical Journal. 2017; 59: 171-177. 
46. Opie R, Itsiopoulos C, Parletta N, Sanchez-Villegas A, Akbaraly N, Ruusunen 
A, et al. Dietary recommendations for the prevention of depression. Nutr 
Neurosci. 2017; 20: 161-171. 
47. Makizako H, Liu-Ambrose T, Shimada H, Doi T, Park H, Tsutsumimoto K, 
et al. Moderate-intensity physical activity, hippocampal volume, and memory 
in older adults with mild cognitive impairment. J Gerontol A BiolSci Med Sci. 
2015; 70 : 480-486. 
48. Morris JK, Vidoni ED, Johnson DK, Van Sciver A, Mahnken JD, Honea RA, 
et al. Aerobic exercise for Alzheimer’s disease: A randomized controlled pilot 
trial. PLOS ONE. 2017; 12: 0170547. 
49. Travers C. Increasing enjoyable activities to treat depression in nursing home 
residents with dementia: A pilot study. Dementia. 2017; 16: 204-218.
50. Olsen C, Pedersen I, Bergland A, Enders-Slegers M, Patil G and Ihlebæk C. 
Effect of animal-assisted interventions on depression, agitation and quality 
of life in nursing home residents suffering from cognitive impairment or 
dementia: a cluster randomized controlled trial. Int J Geriatr Psychiatry. 2016; 
31: 1312-1321. 
51. Wang S, Yu C and Chang S. Effect of music care on depression and 
behavioral problems in elderly people with dementia in Taiwan: a quasi-
experimental, longitudinal study. Aging Ment Health. 2017; 21: 156-162. 
52. Gomez Gallego M and Gomez Garcia J. Music therapy and Alzheimer’s 
disease: cognitive, psychological, and behavioural effects. Neurologia. 
2017;32: 300-308.
53. Werner. Alzheimer’s and other dementing diseases, Massage and Body 
Work. 2017; 40-43. 
54. D’Onofrio G, Sancarlo D, Fernandez C, Addante F, Seripa D and Greco, A. 
Frailty level in Alzheimer’s disease patients predicts the caregiver burden 
level. SM Group. 2017. 
55. Mohamed S, Rosenheck R, Lyketsos K and Schneider LS. Caregiver burden 
in Alzheimer’s disease: cross sectional and longitudinal patient correlates. 
Am J Geriatr Psychiatry. 2010; 18: 917-927. 
56. Liu Shuai, Li C, Shi Z, Wang X, Zhou Y, Shuling, Y, Liu, Shuling et al. Caregiver 
burden and prevalence of depression, anxiety and sleep disturbances in 
Alzheimer’s disease caregivers in China. J ClinNurs. 2016; 26, 1291-1300.
57. Seeher K, Low LF, Reppermund S and Brodaty H. Predictors and outcomes 
for caregivers of people with mild cognitive impairment: a systematic literature 
review. Alzheimers Dement. 2013; 9: 346-355.
58. Feast A, Orrell M, Russell I, Charles worth G and Moniz-Cook E. The 
contribution of caregiver psychosocial factors to distress associated with 
behavioral and psychological symptoms in dementia. Int J Geriatr Psychiatry. 
2017; 32: 76-85. 
59. Alzheimer Society. Ambiguous loss and grief: A resource for health care 
providers. Toronto ON: Author 2013.
